全文获取类型
收费全文 | 6986篇 |
免费 | 657篇 |
国内免费 | 352篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 180篇 |
妇产科学 | 154篇 |
基础医学 | 1251篇 |
口腔科学 | 108篇 |
临床医学 | 382篇 |
内科学 | 765篇 |
皮肤病学 | 26篇 |
神经病学 | 602篇 |
特种医学 | 460篇 |
外国民族医学 | 7篇 |
外科学 | 448篇 |
综合类 | 1455篇 |
现状与发展 | 2篇 |
预防医学 | 205篇 |
眼科学 | 185篇 |
药学 | 772篇 |
3篇 | |
中国医学 | 265篇 |
肿瘤学 | 690篇 |
出版年
2024年 | 19篇 |
2023年 | 73篇 |
2022年 | 143篇 |
2021年 | 215篇 |
2020年 | 193篇 |
2019年 | 161篇 |
2018年 | 168篇 |
2017年 | 239篇 |
2016年 | 265篇 |
2015年 | 305篇 |
2014年 | 356篇 |
2013年 | 521篇 |
2012年 | 402篇 |
2011年 | 423篇 |
2010年 | 342篇 |
2009年 | 361篇 |
2008年 | 396篇 |
2007年 | 366篇 |
2006年 | 364篇 |
2005年 | 350篇 |
2004年 | 310篇 |
2003年 | 271篇 |
2002年 | 199篇 |
2001年 | 184篇 |
2000年 | 146篇 |
1999年 | 125篇 |
1998年 | 99篇 |
1997年 | 102篇 |
1996年 | 99篇 |
1995年 | 97篇 |
1994年 | 87篇 |
1993年 | 59篇 |
1992年 | 60篇 |
1991年 | 67篇 |
1990年 | 41篇 |
1989年 | 46篇 |
1988年 | 21篇 |
1987年 | 26篇 |
1986年 | 33篇 |
1985年 | 41篇 |
1984年 | 44篇 |
1983年 | 11篇 |
1982年 | 29篇 |
1981年 | 30篇 |
1980年 | 22篇 |
1979年 | 16篇 |
1978年 | 23篇 |
1977年 | 10篇 |
1976年 | 19篇 |
1974年 | 4篇 |
排序方式: 共有7995条查询结果,搜索用时 31 毫秒
961.
962.
963.
Pulmonary venous changes in chronic hypoxia 总被引:3,自引:0,他引:3
C. A. Wagenvoort Noeke Wagenvoort 《Virchows Archiv : an international journal of pathology》1976,372(1):51-56
Summary Lung tissue from 14 normal residents of high altitude regions, 10 patients with chronic bronchitis and emphysema, and 1 patient with Pickwickian syndrome was studied with regard to the occurrence of pulmonary vascular changes. In addition to the well-known pulmonary arterial alterations, lesions in small pulmonary veins were found in the great majority of the cases. These changes, consisting of medial hypertrophy and arterialization and of bundles of smooth muscle cells within the venous intima, have not been described before in man. These findings suggest that alveolar hypoxia acts not only on small pulmonary arteries and arterioles but also on veins of small caliber, probably by inducing venoconstriction. 相似文献
964.
丹参酮有关化合物的合成 总被引:9,自引:0,他引:9
药理试验表明丹参酮IIA及隐丹参酮等有耐缺氧作用。丹参酮IIA等的耐缺氧作用,可能与其邻醌结构有关。我们合成了一些改变醌式结构的丹参酮类似物,经试验,它们的耐缺氧作用减弱。丹参酮IIA由于磺酸基的引入而成水溶性化合物,临床试验对冠心病有效。但存在一些缺点,为了寻找更好的水溶性的丹参酮类化合物,合成了若干丹参酮Ⅰ和IIA的Mannich碱,药理试验表明有较好的抑菌作用。有关心血管方面的药理将另文报道。 相似文献
965.
Ide T Kitajima Y Miyoshi A Ohtsuka T Mitsuno M Ohtaka K Koga Y Miyazaki K 《International journal of cancer. Journal international du cancer》2006,119(12):2750-2759
The hypoxic environment in tumor is reported to play an important role in pancreatic cancer progression. The interaction between stromal and cancer cells also contributes to the malignant behavior of pancreatic cancer. In the present study, we investigated whether hypoxic stimulation affects stromal as well as pancreatic cancer cells. Our findings demonstrated that hypoxia remarkably elevated the HIF-1alpha expression in both pancreatic cancer (PK8) and fibroblast cells (MRC5). Hypoxic stimulation accelerated the invasive activity of PK8 cells, and invasiveness was thus further accelerated when the hypoxic PK8 cells were cultured with conditioned medium prepared from hypoxic MRC5 cells (hypoxic conditioned medium). MMP-2, MMP-7, MT1-MMP and c-Met expressions were increased in PK8 cells under hypoxia. Hypoxic stimulation also increased the hepatocyte growth factor (HGF) secretion from MRC5 cells, which led to an elevation of c-Met phosphorylation in PK8 cells. Conversely, the elevated cancer invasion, MMP activity and c-Met phosphorylation of PK8 cells were reduced by the removal of HGF from hypoxic conditioned medium. In immunohistochemical study, the HIF-1alpha expression was observed in surrounding stromal as well as pancreatic cancer cells, thus indicating hypoxia exists in both of cancer and stromal cells. Moreover, the stromal HGF expression was found to significantly correlate with not only the stromal HIF-1alpha expression but also the c-Met expression in cancer cells. These results indicate that the hypoxic environment within stromal as well as cancer cells activates the HGF/c-Met system, thereby contributing to the aggressive invasive features of pancreatic cancer. 相似文献
966.
Vlahovic G Rabbani ZN Herndon JE Dewhirst MW Vujaskovic Z 《British journal of cancer》2006,95(8):1013-1019
Elevated intratumoral interstitial fluid pressure (IFP) and tumour hypoxia are independent predictive factors for poor survival and poor treatment response in cancer patients. However, the relationship between IFP and tumour hypoxia has not yet been clearly established. Preclinical studies have shown that lowering IFP improves treatment response to cytotoxic therapy. Interstitial fluid pressure can be reduced by inhibition of phosphorylated platelet-derived growth factor receptor-beta (p-PDGFR-beta), a tyrosine kinase receptor frequently overexpressed in cancer stroma, and/or by inhibition of VEGF, a growth factor commonly overexpressed in tumours overexpressing p-PDGFR-beta. We hypothesised that Imatinib, a specific PDGFR-beta inhibitor will, in addition to p-PDGFR-beta inhibition, downregulate VEGF, decrease IFP and improve tumour oxygenation. A549 human lung adenocarcinoma xenografts overexpressing PDGFR-beta were grown in nude mice. Tumour-bearing animals were randomised to control and treatment groups (Imatinib 50 mg kg(-1) via gavage for 4 days). Interstitial fluid pressure was measured in both groups before and after treatment. EF5, a hypoxia marker, was administered 3 h before being killed. Tumours were sectioned and stained for p-PDGFR-beta, VEGF and EF5 binding. Stained sections were viewed with a fluorescence microscope and image analysis was performed. Imatinib treatment resulted in significant reduction of p-PDGFR-beta, VEGF and IFP. Tumour oxygenation was also significantly improved. This study shows that p-PDGFR-beta-overexpressing tumours can be effectively treated with Imatinib to decrease tumour IFP. Importantly, this is the first study demonstrating that Imatinib treatment improves tumour oxygenation and downregulates tumour VEGF expression. 相似文献
967.
968.
Humphreys MR Ereth MH Sebo TJ Slezak JM Dong Y Blute ML Gettman MT 《BJU international》2006,98(3):674-679
OBJECTIVE: To investigate renal preservation by a novel method of perfusion using an oxygenated perfluorocarbon (PFC) emulsion via retrograde access to the kidney, as preserving renal function during urological surgery has been elusive, and the recognized technique of nephron-sparing surgery has increased its application and practice in modern urology. MATERIALS AND METHODS: After institutional review and approval, 30 New Zealand White rabbits were studied. In a solitary kidney model, each rabbit had the ureter catheterized before 40 min of renal artery occlusion. Each rabbit was randomized to one retrograde perfusion group, i.e. sham, normothermic PFC, chilled PFC, normothermic saline, and chilled saline. The rabbits were maintained for 2 weeks, during which renal function, urine output, systemic blood gases, weight and serum creatinine level were measured. After death, the kidneys were individually examined and graded by one renal pathologist unaware of the treatment. RESULTS: The rabbits treated with retrograde PFC perfusion (normothermic and chilled) had less change in their creatinine clearance, at 3.6 and 4.0 mL/min per kg, than the sham group, at 7.8 mL/min per kg, while also having significantly higher systemic venous oxygenation, at 26.3 and 10.0 mmHg, than the sham group, at 0.2 mmHg. Normothermic and chilled perfusion with PFC was also associated with less histological evidence of ischaemic damage, with mean (sd) scores of 13.0 (13.5) and 8.7 (4.5), respectively, than in the sham group, at 33.3 (16.8), while favourably matching the contralateral control kidney group, at 5.5 (2.3). The rabbits treated with saline retrograde perfusion also had better outcomes than the sham cohort. There were no adverse effects in any of the study arms or with the use of PFC. CONCLUSION: Retrograde oxygen delivery to the kidney through the urinary collecting system was successful in this pilot study. Renal function, laboratory and histological data indicate a trend towards renal preservation and even systemic oxygenation in the experimental groups compared with the sham rabbits, with no adverse effects attributed to this technique. 相似文献
969.
970.
Abstract: Survival of 4 days old rats exposed to 6% O2-94% N2 was studied. Administration of L-DOPA (100 mg/kg) or L-5-HTP (100 mg/kg) reduced survival during hypoxia to about 30% of controls. A further reduction of survival time was noted after combined administration of L-DOPA and L-5-HTP. Administration of increasing doses of L-DOPA or L-5-HTP resulted in a dose-related decrease in neonatal survival time. After inhibition of the peripheral L-aminoacid decarboxylase with MK-486, L-DOPA caused the same reduction of survival time during hypoxia as after L-DOPA alone. Clonidine (2 mg/kg) was found to reduce hypoxic survival time to about 60%, while apomorphine had no effect compared to controls. Clonidine and apomorphine together had the same effect as clonidine alone. It is suggested that central monoamine neurotransmitters are involved in the mechanisms determining survival during neonatal oxygen deprivation. 相似文献